Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-023018
Filing Date
2024-09-06
Accepted
2024-09-06 16:30:11
Documents
1
Period of Report
2024-09-05

Document Format Files

Seq Description Document Type Size
1 form4-09062024_040902.html 4  
1 form4-09062024_040902.xml 4 4051
  Complete submission text file 0001415889-24-023018.txt   5531
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANNEXON, INC. 180 KIMBALL WAY, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Yednock Ted (Reporting) CIK: 0001818525 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39402 | Film No.: 241284887